Prevention & care
Food sensitivity panels: IgG, true allergy tests, intolerance and emerging IBS research
On this page
Food sensitivity is a broad label, not one defined disease with one diagnostic test. Commercial IgG panels measure antibodies to many foods. Detecting these antibodies can reflect exposure and does not, by itself, show that a food causes symptoms.[1]
Different concerns require different assessments
| Test or quantity | What it examines | Interpretation boundary |
|---|---|---|
| Suspected IgE-mediated allergy | History plus appropriate IgE or skin tests; sometimes supervised challenge | A positive antibody result alone is insufficient[3] |
| Lactose intolerance | Digestion of lactose and symptoms, sometimes assessed by breath testing | This does not require a broad food-antibody panel[4] |
| Celiac disease | Disease-specific antibodies and, when indicated, intestinal biopsies | Testing requires the relevant diet and antibody context[5] |
| Commercial food IgG panel | Antibodies detected against a list of foods | Exposure is not proof of a harmful reaction[1] |
An immune test is interpreted with the reaction history
Food-specific IgE and skin testing can assist an allergy investigation, but positive findings can occur without clinical allergy. An allergist interprets symptoms and history and may use a medically supervised food challenge. Do not recreate a suspected allergic exposure at home to check a commercial panel.[3]
Malabsorption and symptoms have a targeted assessment
A lactose hydrogen-breath test gives a known amount of lactose and measures breath hydrogen over time while recording symptoms. NIDDK distinguishes difficulty absorbing lactose from the symptom-based diagnosis of intolerance. This evaluates a digestive question, not every suspected food reaction.[4]
The antibody target matters more than its class name
Celiac evaluation uses specified antibodies such as tissue-transglutaminase and endomysial antibodies. IgA-based tests are preferred, while particular IgG tests can help when IgA deficiency is present. NIDDK explains that gluten must be included in the diet for accurate diagnostic testing. Some positive serology requires biopsy confirmation. A clinically indicated celiac antibody test is therefore not equivalent to screening many foods for IgG reactivity. Calling both blood panels obscures their different targets, indications and validation.[5]
Evidence & uncertainty
CSACI’s May 2025 recommendations discourage food-specific IgG panels for diagnosing adverse reactions. This claim must be distinguished from a narrower research question: whether a particular test-guided diet improves symptoms in selected people with IBS. Diagnostic accuracy and treatment benefit are different outcomes.[2]
Selected-source overview · Independent review pendingPublished questions
Does a high food IgG result prove that food causes symptoms?
Selected-source overview · Independent review pending. Read the evidence context.
No. IgG can reflect exposure; broad panels do not diagnose food reactions. The actual test’s validation matters.[1]
Evidence behind this answer
- The myth of IgG food panel testing
professional association explanation · Date not stated
Selected relevant original official educational passages inspected · Exposure, tolerance and lack of broad diagnostic validation
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does a positive food-specific IgE result always mean allergy?
Selected-source overview · Independent review pending. Read the evidence context.
No. An allergist interprets the result with the reaction history and may use a supervised challenge. An antibody result alone cannot confirm allergy or its severity. Avoid self-directed food challenges when allergy is suspected.[3]
Evidence behind this answer
- Food allergy testing
agency condition or prevention explanation · Date not stated
Selected relevant original official educational passages inspected · What the test measures; uses; preparation; meaning of results
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does suspected lactose intolerance require a large antibody panel?
Selected-source overview · Independent review pending. Read the evidence context.
No. A targeted assessment can use history and, when appropriate, lactose breath testing with symptom recording. It examines digestion of lactose rather than a list of food antibodies.[4]
Evidence behind this answer
- Diagnosis of lactose intolerance
agency condition or prevention explanation · Date not stated
Selected relevant original official educational passages inspected · Hydrogen breath test, symptom recording and malabsorption
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Are all IgG blood tests medically unsupported?
Selected-source overview · Independent review pending. Read the evidence context.
No. Specific celiac IgG tests can have a role in people with IgA deficiency. Their defined targets and indications differ from broad commercial food-reactivity panels. Assess the actual test, rather than dismissing an entire antibody class.[5]
Evidence behind this answer
- Celiac disease tests
agency condition or prevention explanation · Date not stated
Selected relevant original official educational passages inspected · Specific serology, gluten intake, IgA deficiency and biopsy
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Do positive IBS diet trials validate every food sensitivity panel?
Selected-source overview · Independent review pending. Read the evidence context.
No. The 2025 study tested a particular IBS-specific assay and eight-week intervention against a sham diet. Its response endpoint concerns symptom improvement, not universal allergy diagnosis. Other products and populations require their own evidence.[6]
Evidence behind this answer
- IBS-specific IgG assay guided diet: randomized sham-controlled trial
randomized controlled trial · 2025
Original indexed abstract methods and results inspected; direct PubMed retrieval provided no readable article; no independent full-text appraisal · Indexed original abstract: methods, eight-week pain endpoint and results
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Was the newer Alcat study an IgG diagnostic-accuracy trial?
Selected-source overview · Independent review pending. Read the evidence context.
No. It assessed a specific cell-response-guided diet in a small IBS population. Short-term symptom response, baseline imbalance and study limitations should not be converted into a general diagnostic claim for commercial IgG panels.[7]
Evidence behind this answer
- Immune-based personalized elimination diet for IBS
randomized controlled trial · 2026
Selected original full-text methods, results, limitations and funding passages inspected; no independent full-text appraisal · Methods, results, limitations, retrospective registration and funding
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
A colored food list is not a proven set of triggers
CSACI explains that food-specific IgG indicates previous exposure rather than hypersensitivity and can lead to inappropriate diagnosis and treatment when used as a broad allergy test. The same panel result cannot validate every claimed use for headaches, fatigue, digestive symptoms or other concerns. An observed improvement after changing a diet also does not, by itself, establish that each flagged food was responsible. Several foods, amounts and eating patterns may have changed together; a useful evaluation needs the actual symptom question.[2]
A positive 2025 trial answers a narrower IBS question
A randomized, double-blind, sham-controlled trial used an IBS-specific 18-food IgG assay to guide an eight-week elimination diet. In 223 participants in the modified intention-to-treat analysis, 59.6% on the guided diet met the abdominal-pain response endpoint, compared with 42.1% on the sham diet: a 17.5 percentage-point difference. The endpoint required at least 30% less pain during at least two of the final four weeks. This supports further investigation of that assay and intervention in its selected IBS population. It does not validate every consumer panel or demonstrate that a positive food antibody diagnoses allergy. The authors called for a larger validation study.[6]
A different 2026 test-guided diet also needs careful interpretation
A single-center trial of an Alcat-based diet enrolled 68 people with diarrhea-predominant or mixed IBS. At eight weeks, 30/35 guided-diet participants and 18/33 controls achieved at least a 50-point reduction in symptom severity. Baseline severity differed between groups; the study was small, used self-reported outcomes and registered after study initiation. Cell Science Systems funded the work. This finding concerns a diet-selection strategy and a particular cell-response assay, not the diagnostic performance of IgG panels. Independent replication and longer follow-up remain important before broad conclusions.[7]
References
- The myth of IgG food panel testing
Professional association explanation
AAAAI · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Selected relevant original official educational passages inspected
Cited sections: Exposure, tolerance and lack of broad diagnostic validation - Allergy and clinical immunology recommendations
Clinical guideline
CSACI / Choosing Wisely Canada · Content/publication date: 2025
Accessed: 2026-10-13 UTC · Selected relevant original official educational passages inspected
Cited sections: Recommendation 1; food-specific IgG indicates exposure rather than hypersensitivity - Food allergy testing
Agency condition or prevention explanation
NIH / National Library of Medicine · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Selected relevant original official educational passages inspected
Cited sections: What the test measures; uses; preparation; meaning of results - Diagnosis of lactose intolerance
Agency condition or prevention explanation
NIDDK · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Selected relevant original official educational passages inspected
Cited sections: Hydrogen breath test, symptom recording and malabsorption - Celiac disease tests
Agency condition or prevention explanation
NIDDK · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Selected relevant original official educational passages inspected
Cited sections: Specific serology, gluten intake, IgA deficiency and biopsy - IBS-specific IgG assay guided diet: randomized sham-controlled trial
Randomized controlled trial
Singh and colleagues · Content/publication date: 2025
Accessed: 2026-10-13 UTC · Original indexed abstract methods and results inspected; direct PubMed retrieval provided no readable article; no independent full-text appraisal
Cited sections: Indexed original abstract: methods, eight-week pain endpoint and results - Immune-based personalized elimination diet for IBS
Randomized controlled trial
Ukashi and colleagues · Content/publication date: 2026
Accessed: 2026-10-13 UTC · Selected original full-text methods, results, limitations and funding passages inspected; no independent full-text appraisal
Cited sections: Methods, results, limitations, retrospective registration and fundingPublished June 12, 2026; trial conducted 2020–2022; industry grant disclosed
Scope & review
- Population
- General readers learning about clinical testing and consumer test claims; no individualized diagnosis
- Exposure or intervention
- Food sensitivity panels
- Comparison
- Indication-specific alternatives; screening, diagnostic evaluation and monitoring distinguished
- Outcomes
- Meaning of measurements, appropriate indications, collection requirements and limits of inference
- Timeframe
- A specimen or examination at a stated time; trends and follow-up depend on clinical context
- Jurisdiction
- Selected US agency sources, dated professional guidance and original international research; jurisdiction and eligibility are source-specific
Selected-source educational explanation. Official guidance, original study findings and editorial interpretation are distinguished. No exhaustive search, independent systematic synthesis or qualified medical review has been completed.
Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.
Revision history
- 2026-10-13 UTC: Added a selectively sourced diagnostic-test explanation; qualified independent review remains pending.
What this article still leaves open
- Do independent replications show that an assay adds benefit beyond a well-supported dietary assessment?
- Which test-guided interventions have durable benefit without unnecessary dietary restriction?
Suggest a correction
Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.
Your submitted corrections for this article
Explore the topic map
Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.